Perphenazine and Myrbetriq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perphenazine (perphenazine) and Myrbetriq (mirabegron). Common drug interactions include abscess oral among females.

The phase IV clinical study analyzes what interactions people have when they take Perphenazine and Myrbetriq. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Perphenazine?

Perphenazine has active ingredients of perphenazine. It is often used in bipolar i disorder. eHealthMe is studying from 2,712 Perphenazine users. Check the latest studies of Perphenazine.

What is Myrbetriq?

Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.



On Jul, 31, 2026

13 people who take Perphenazine and Myrbetriq together, and have interactions are studied.

Perphenazine and Myrbetriq drug interactions.

What are the common drug interactions of Perphenazine and Myrbetriq, by gender? *:

female:

  1. Abscess oral (abscess in the mouth)
  2. Cellulitis (infection under the skin)
  3. Drug hypersensitivity
  4. Memory impairment
  5. Seasonal allergy (allergic condition due to certain season)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chronic kidney disease
  8. Infusion site bruising
  9. Infusion site reaction
  10. Myalgia (muscle pain)

male:

n/a

What are the common drug interactions of Perphenazine and Myrbetriq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Obesity (having too much body fat)
  2. Pain
  3. Cerebrovascular disorder (disease of brain)
  4. Chronic kidney disease
  5. Abscess oral (abscess in the mouth)
  6. Cellulitis (infection under the skin)
  7. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  8. Substance abuse
  9. Allergy to metals
  10. Drug hypersensitivity

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 61.54%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 61.54%
  3. Urinary Tract Infection: 1 person, 7.69%
  4. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 7.69%
  5. Bipolar Disorder (mood disorder): 1 person, 7.69%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
  7. Constipation: 1 person, 7.69%
  8. Depression: 1 person, 7.69%
  9. Drowsiness: 1 person, 7.69%
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Perphenazine and Myrbetriq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Perphenazine and Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perphenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Myrbetriq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on perphenazine and mirabegron (the active ingredients of Perphenazine and Myrbetriq, respectively), and Perphenazine and Myrbetriq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: